2 years ago
ASRT
AnalystsThomas FlatenThomas Flaten's Stock Forecasts
AnalystsThomas Flaten
Analyst Ranking
Bottom 3%
#4752 out of 4873 analysts
Average Return
-12.27%
Win Rate
28%10 out of 36
Risk vs Reward
Poor
Good
Thomas Flaten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Diamedica Therapeutics IncDMAC | +220.63% | $1.26 | $4.04 | 2022-07-06 - 2023-07-06 | Strong Buy |
Personalis IncPSNL | +158.50% | $1.47 | $3.80 | 2024-04-29 - 2025-04-29 | Strong Buy |
Biolife Solutions IncBLFS | +152.95% | $15.77 | $39.89 | 2020-02-23 - 2021-02-24 | Strong Buy |
Castle Biosciences IncCSTL | +101.72% | $11.66 | $23.52 | 2023-06-04 - 2024-06-04 | Strong Buy |
Biolife Solutions IncBLFS | +73.46% | $13.11 | $22.74 | 2023-08-08 - 2024-08-08 | Strong Buy |
Thomas Flaten Analyst Color
Get additional color on Thomas Flaten's coverage of popular stocks
Thomas Flaten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Castle Biosciences IncCSTL | 6 | Strong Buy | $35.00 | +103.37% | Maintains | 2 days ago |
Oncocyte CorpOCX | 4 | Strong Buy | $5.00 | +76.06% | Initiates Coverage On | a month ago |
Optinose IncOPTN | 4 | Hold | $9.00 | -4.15% | Downgrades | 2 months ago |
Checkpoint Therapeutics IncCKPT | 5 | Hold | $4.10 | -0.97% | Downgrades | 2 months ago |
Aquestive Therapeutics IncAQST | 2 | Strong Buy | $8.00 | +189.86% | Maintains | 2 months ago |
Evaxion Biotech AEVAX | 2 | Strong Buy | $6.00 | +313.79% | Maintains | 3 months ago |
Personalis IncPSNL | 2 | Strong Buy | $9.00 | +74.42% | Maintains | 4 months ago |
Journey Medical CorpDERM | 1 | Strong Buy | $9.00 | +30.81% | Initiates Coverage On | 8 months ago |
Dermtech IncDMTKQ | 1 | Hold | $0.63 | N/A | Downgrades | a year ago |
Assertio Holdings IncASRT | 3 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Achieve Life Sciences IncACHV | 3 | Strong Buy | $11.00 | N/A | Maintains | a year ago |
Better Therapeutics IncBTTX | 2 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Diamedica Therapeutics IncDMAC | 1 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ensysce Biosciences IncENSC | 1 | Strong Buy | $14,400.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.